• $8.2M
    Market Cap
  • -77.93%
    1-Year Change
  • Diagnostics & Research
    Industry
Annual
Quarterly
06/30/2025
Income Statement
Total Operating Revenue
N/A
N/A
Cost of Revenue
N/A
N/A
Gross Profit
0
N/A
Sales and Marketing Expense
N/A
N/A
Research and Development Expense
-909,771
N/A
Depreciation and Amortization Expense
343,830
N/A
Total Operating Expenses
3.0M
N/A
Operating Profit
-3.3M
N/A
Interest Income
24,915
N/A
Interest Expense
N/A
N/A
Interest Income and Expense and Net
24,915
N/A
Total Nonoperating Income and Expense
-237,933
N/A
Income before Taxes
-3.3M
N/A
Income Taxes
2.0M
N/A
Extraordinary Items
N/A
N/A
Net Income
-3.3M
N/A
Net Income from Continuing Operations Applicable to Common
-3.3M
N/A
Basic EPS and Net Income
-0.16
N/A
Diluted EPS and Net Income
-0.16
N/A
Basic Weighted Average Shares
20.5M
N/A
Diluted Weighted Average Shares
20.5M
N/A
Balance Sheet
Cash and Cash Equivalents
2.9M
N/A
Short-Term Investments
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
2.9M
N/A
Total Current Assets
6.0M
N/A
Accumulated Depreciation
1.6M
N/A
Property and Plant and Equipment and Net
331,346
N/A
Total Long-Term Assets
479,772
N/A
Total Assets
6.5M
N/A
Income Taxes Payable
N/A
N/A
Total Short-Term Debt
N/A
N/A
Total Current Liabilities
2.9M
N/A
Total Long-Term Debt
455,992
N/A
Total Long-Term Liabilities
145,651
N/A
Total Liabilities
3.0M
N/A
Retained Earnings
-19.2M
N/A
Total Stockholders Equity
3.5M
N/A
Total Shares Outstanding
21.6M
N/A
Cash Flow
Cash from Operating Activities
-5.8M
N/A
Capital Expenditures
31,650
N/A
Cash from Investing Activities
-31,650
N/A
Dividends Paid
N/A
N/A
Cash from Financing Activities
5.9M
N/A
Financials Ratio
Gross Margin
N/A
N/A
Operating Margin
N/A
N/A
Return on Assets
N/A
N/A
Return on Equity
N/A
N/A
Revenue Growth
N/A
N/A
Current Ratio
N/A
N/A
Cash Ratio
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow